Continuous blood glucose monitors have been promoted as potentially life-changing for people with diabetes -- allowin ...

Continuous glucose monitors consistently overestimate fasting and post-meal blood glucose levels compared to capillary blood ...

Senseonics Holdings Inc. ( ($SENS) ) has released its Q4 earnings. Here is a breakdown of the information Senseonics Holdings Inc. presented to ...

Senseonics Holdings, Inc. ( NYSE: SENS) Q4 2024 Earnings Conference Call March 3, 2025 4:30 PM ET Jeremy Feffer - Investor Relations, LifeSci Advisors Tim Goodnow - President and Chief Executive ...

Received FDA approval for Eversense® 365 Continuous Glucose Monitoring system and launched Eversense 365 with commercial partner, AscensiaPatient ...

Welcome to the era of algorithm-driven diabetes management—where closed-loop glucose monitoring systems keep you from tanking ...

Senseonics Holdings and Ascensia Diabetes Care announce the integration of SweetSpot with the Eversense 365 Continuous Glucose Monitoring (CGM) System in the U.S ...

Defender has unveiled the Smart Boot™, an intelligent protective device that reduces forces on the foot to aid in wound ...

FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

The US Food and Drug Administration (FDA) has cleared Tandem Diabetes Care’s Control-IQ+ technology, an automated insulin ...

Senseonics announced today that it integrated SweetSpot software with its Eversense 365 continuous glucose monitor (CGM) in ...